|
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3153-3160.
Prepublished online as a Blood First Edition Paper on July 29, 2004; DOI 10.1182/blood-2004-03-0809.
Previous Article | Next Article 
Submitted March 5, 2004
Accepted July 18, 2004
Erythroblasts secrete the non classical HLA-G molecule from primitive to definitive hematopoiesis
Catherine Menier, Michele Rabreau, Jean-Claude Challier, Magali Le Discorde, Edgardo D Carosella, and Nathalie Rouas-Freiss*
Service de Recherches en Hemato-Immunologie, Hopital de Saint Louis, Paris, France
Institut d'Histo-Cyto-Pathologie, Laboratoire de Foetopathologie, Bordeaux, France
Physiopathologie de l'Implantation et du Developpement, Universite Pierre et Marie Curie, Paris, France
* Corresponding author; email: freiss{at}dsvidf.cea.fr.
The initial steps of primitive hematopoiesis and endothelial vascular formation in the human embryo remain to be defined. Here we report the identification of a novel marker, namely the non classical HLA-G class I molecule which targets both primitive erythroid cells of the yolk sac and endothelial cells from developing vessels. Moreover, HLA-G was present in its soluble form in the erythropoietic lineage in all organs sustaining primitive to definitive erythropoiesis (i.e., aorta-gonad-mesonephros, liver, spleen and bone marrow). The alternatively spliced transcript coding the soluble HLA-G5 molecule was detected in erythroid cells. The corresponding intron 4-retaining 37 kilodalton-HLA-G5 isoform was secreted from the erythroid progenitor stage to the reticulocyte, but was lost in mature erythrocytes and in endothelial cells from differentiated vessels. This study constitutes the first description of an HLA class I antigen expression on the primitive erythroid lineage and provides a way of seeking out both primitive and definitive erythropoiesis using HLA-G5. This new marker, previously known by its immunotolerogeneic properties, may be involved in erythroid differentiation and/or angiogenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Flajollet, I. Poras, E. D. Carosella, and P. Moreau
RREB-1 Is a Transcriptional Repressor of HLA-G
J. Immunol.,
December 1, 2009;
183(11):
6948 - 6959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bahri, A. Naji, C. Menier, B. Charpentier, E. D. Carosella, N. Rouas-Freiss, and A. Durrbach
Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance
J. Immunol.,
December 1, 2009;
183(11):
7054 - 7062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. WASTOWSKI, P. D. SAMPAIO-BARROS, E. M.I. AMSTALDEN, G. M. PALOMINO, J. F. MARQUES-NETO, J. C.O. CRISPIM, A. C. BIRAL, D. M. RASSI, E. D. CAROSELLA, P. MOREAU, et al.
HLA-G Expression in the Skin of Patients with Systemic Sclerosis
J Rheumatol,
June 1, 2009;
36(6):
1230 - 1234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sheshgiri, V. Rao, L. C. Tumiati, R. Xiao, J. L. Prodger, M. Badiwala, C. Librach, and D. H. Delgado
Progesterone Induces Human Leukocyte Antigen-G Expression in Vascular Endothelial and Smooth Muscle Cells
Circulation,
September 30, 2008;
118(14_suppl_1):
S58 - S64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Moreau, L. Contu, F. Alba, S. Lai, R. Simoes, S. Orru, C. Carcassi, M. Roger, M. Rabreau, and E. D. Carosella
HLA-G Gene Polymorphism in Human Placentas: Possible Association of G*0106 Allele with Preeclampsia and Miscarriage
Biol Reprod,
September 1, 2008;
79(3):
459 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. LeMaoult
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Blood,
May 15, 2008;
111(10):
4862 - 4870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Le Rond, C. Azema, I. Krawice-Radanne, A. Durrbach, C. Guettier, E. D. Carosella, and N. Rouas-Freiss
Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells.
J. Immunol.,
March 1, 2006;
176(5):
3266 - 3276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Q. Yao, D. H. Barlow, and I. L. Sargent
Differential Expression of Alternatively Spliced Transcripts of HLA-G in Human Preimplantation Embryos and Inner Cell Masses
J. Immunol.,
December 15, 2005;
175(12):
8379 - 8385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Blaschitz, H. Juch, A. Volz, H. Hutter, C. Daxboeck, G. Desoye, and G. Dohr
The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms
Mol. Hum. Reprod.,
October 1, 2005;
11(10):
699 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. LeMaoult, N. Rouas-Freiss, and E. D. Carosella
HLA-G5 expression by trophoblast cells: the facts
Mol. Hum. Reprod.,
October 1, 2005;
11(10):
719 - 722.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Blaschitz, H. Juch, A. Volz, H. Hutter, and G. Dohr
Soluble HLA-G, the discussion is going on!
Mol. Hum. Reprod.,
October 1, 2005;
11(10):
723 - 727.
[Full Text]
[PDF]
|
 |
|
|
|